YSB Inc. (HK:9885)
:9885
Want to see HK:9885 full AI Analyst Report?
9885 Stock Chart & Stats
HK$5.16
HK$0.08(1.41%)
At close: 4:00 PM EST
HK$5.16
HK$0.08(1.41%)
Day’s Range― - ―
52-Week RangeHK$3.56 - HK$12.66
Previous CloseN/A
Volume1.48M
Average Volume (3M)9.20M
Market Cap
HK$2.64B
Enterprise ValueHK$2.75B
Total Cash (Recent Filing)HK$3.38B
Total Debt (Recent Filing)HK$2.77B
Price to Earnings (P/E)21.9
Beta0.82
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.38%
Share Statistics
EPS (TTM)0.22
Shares Outstanding688,070,900
10 Day Avg. Volume7,414,414
30 Day Avg. Volume9,200,413
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.37
Price to Sales (P/S)0.16
P/FCF Ratio5.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.38
Revenue Forecast (FY)HK$23.46B
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistently positive and growing free cash flow (FCF up ~27% in 2025) provides durable internal funding for operations, R&D, and shareholder returns without immediate external financing. Strong FCF alignment with reported profits enhances earnings credibility and cushions the business through cyclical pressure.
Revenue & Profit ReboundA return to positive EBIT and net income in 2025 alongside steady revenue growth (annual growth ~7.9% in 2025) indicates the business model can scale toward profitability. This structural improvement supports longer-term reinvestment and demonstrates operational leverage as scale expands.
Improved Balance SheetEquity recovery to ~2.44B and a positive ROE (~6.1%) reflect restored solvency and the ability to generate returns on capital. A healthier equity base reduces restructuring risk, supports credit access, and gives management more optionality for strategic investments over the medium term.
Bears Say
Low MarginsMargins are very thin for a software company (gross ~11%, net <1% in 2025), leaving profits highly sensitive to small cost increases or pricing pressure. Persistently low margins constrain reinvestment, limit operating leverage benefits, and raise the bar for sustainable, high-quality earnings growth.
Increased LeverageA sharp increase in debt and a debt-to-equity near 1.13 materially reduces financial flexibility. Higher leverage elevates interest and refinancing risk, constrains capital allocation choices, and makes the company more vulnerable if cash flow growth slows or margins compress.
Low Cash ConversionOperating cash flow is small relative to revenue even though absolute FCF is healthy, indicating weak cash conversion. Structurally low cash conversion limits how effectively revenue growth translates to liquidity for capex, debt service, or dividends and increases sensitivity to working capital swings.
YSB Inc. News
9885 FAQ
What was YSB Inc.’s price range in the past 12 months?
YSB Inc. lowest stock price was HK$3.56 and its highest was HK$12.66 in the past 12 months.
What is YSB Inc.’s market cap?
YSB Inc.’s market cap is HK$2.64B.
When is YSB Inc.’s upcoming earnings report date?
YSB Inc.’s upcoming earnings report date is Aug 18, 2026 which is in 89 days.
How were YSB Inc.’s earnings last quarter?
YSB Inc. released its earnings results on Mar 23, 2026. The company reported HK$0.122 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.122.
Is YSB Inc. overvalued?
According to Wall Street analysts YSB Inc.’s price is currently Overvalued.
Does YSB Inc. pay dividends?
YSB Inc. pays a Notavailable dividend of HK$0.081 which represents an annual dividend yield of 1.38%. See more information on YSB Inc. dividends here
What is YSB Inc.’s EPS estimate?
YSB Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does YSB Inc. have?
YSB Inc. has 688,070,900 shares outstanding.
What happened to YSB Inc.’s price movement after its last earnings report?
YSB Inc. reported an EPS of HK$0.122 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.077%.
Which hedge fund is a major shareholder of YSB Inc.?
Currently, no hedge funds are holding shares in HK:9885
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
YSB Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.66%
12-Months-Change
Fundamentals
Return on Equity
6.36%
Trailing 12-Months
Asset Growth
21.86%
Trailing 12-Months
Company Description
YSB Inc.
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. It develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. The company also engages in the wholesale and retail of pharmaceutical and healthcare products. In addition, it provides medical testing services. The company was founded in 2015 and is headquartered in Guangzhou, China.
Technical Analysis
China Youzan
―
Kingdee International Software Group Co
―
Weimob
―
Chanjet Information Technology Co., Ltd. Class H
―
Baiwang Co., Ltd. Class H
―
Options Prices
Currently, No data available
---